NCT04746287View on ClinicalTrials.gov

Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

August 24, 2021

Study Completion Date

August 24, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

CKD-510 single dose

Investigational drug

DRUG

CKD-510 food effect

Investigational drug

DRUG

CKD-510 multiple dose

Investigational drug

DRUG

Placebo

Matching placebo

Trial Locations (1)

Unknown

Clinical site, Grenoble

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY